WEDNESDAY, July 27, 2022 (HealthDay News) — A half-century-old diabetes drug appears to help treat bipolar disorder by reversing patients’ insulin resistance, according to a small-scale clinical trial. Bipolar patients who responded to the drug metformin experienced improvement in their mood disorder as their insulin resistance decreased, said lead researcherContinue Reading

WEDNESDAY, July 27, 2022 (HealthDay News) — They are called “forever chemicals” because they linger in the human body and can contribute to the risk of everything from cancer to childhood obesity. Now, new research on per- and polyfluoroalkyl substances (PFAS) finds they also exact a huge financial toll, costingContinue Reading

WEDNESDAY, July 27, 2022 (HealthDay News) — That phrase “no pain, no gain” might truly apply to people with peripheral artery disease (PAD), a new study finds. Researchers found that people with PAD who walked at pace that caused discomfort or even pain improved their walking ability. “Exercise that inducesContinue Reading

Anxious Americans endure long lines in search for monkeypox vaccine. As infections spread and fear mounts, many people at highest risk for the illness race to get a shot that’s still in short supply throughout the United States. Read more Could a common diabetes drug ease bipolar disorder? Metformin appearsContinue Reading

TUESDAY, July 26, 2022 (HealthDay News) — As monkeypox continues to spread, with nearly 3,500 cases now reported in the United States, the Biden administration is weighing whether to declare the outbreak a public health emergency. The administration may also name a White House coordinator to supervise the response, allContinue Reading